target,target_id,target_uniprot,target_species,ligand,ligand_id,ligand_species,ligand_pubchem_cid,smiles,inchi,inchikey,type,action,action_comment,endogenous,primary_target,concentration_range,affinity_parameter,affinity_high,affinity_median,affinity_low,original_affinity_units,original_affinity_low_nm,original_affinity_median_nm,original_affinity_high_nm,original_affinity_relation,assay_description,receptor_site,ligand_context,pubmed_id Bcl-2-like 1,2845,Q07817,Human,venetoclax,8318,,49846579,Clc1ccc(cc1)C1=C(CCC(C1)(C)C)CN1CCN(CC1)c1ccc(c(c1)Oc1cnc2c(c1)cc[nH]2)C(=O)NS(=O)(=O)c1ccc(c(c1)[N+](=O)[O-])NCC1CCOCC1,"InChI=1S/C45H50ClN7O7S/c1-45(2)15-11-33(39(26-45)31-3-5-34(46)6-4-31)29-51-17-19-52(20-18-51)35-7-9-38(42(24-35)60-36-23-32-12-16-47-43(32)49-28-36)44(54)50-61(57,58)37-8-10-40(41(25-37)53(55)56)48-27-30-13-21-59-22-14-30/h3-10,12,16,23-25,28,30,48H,11,13-15,17-22,26-27,29H2,1-2H3,(H,47,49)(H,50,54)",LQBVNQSMGBZMKD-UHFFFAOYSA-N,Antagonist,Antagonist,,,,,pKi,,7.32,,Ki,,48.0,,=,,,,23291630, Bcl-2-like 1,2845,Q07817,Human,navitoclax,8319,,24978538,Clc1ccc(cc1)C1=C(CN2CCN(CC2)c2ccc(cc2)C(=O)NS(=O)(=O)c2ccc(c(c2)S(=O)(=O)C(F)(F)F)N[C@@H](CSc2ccccc2)CCN2CCOCC2)CC(CC1)(C)C,"InChI=1S/C47H55ClF3N5O6S3/c1-46(2)20-18-42(34-8-12-37(48)13-9-34)36(31-46)32-55-22-24-56(25-23-55)39-14-10-35(11-15-39)45(57)53-65(60,61)41-16-17-43(44(30-41)64(58,59)47(49,50)51)52-38(19-21-54-26-28-62-29-27-54)33-63-40-6-4-3-5-7-40/h3-17,30,38,52H,18-29,31-33H2,1-2H3,(H,53,57)/t38-/m1/s1",JLYAXFNOILIKPP-KXQOOQHDSA-N,Antagonist,Antagonist,,,yes,,pKi,,9.0,,Ki,,1.0,,<,,,,18841882, Bcl-2-like 1,2845,Q07817,Human,ABT-737,8320,,11228183,CN(CC[C@@H](Nc1ccc(cc1[N+](=O)[O-])S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(CC1)Cc1ccccc1c1ccc(cc1)Cl)CSc1ccccc1)C,"InChI=1S/C42H45ClN6O5S2/c1-46(2)23-22-35(30-55-37-9-4-3-5-10-37)44-40-21-20-38(28-41(40)49(51)52)56(53,54)45-42(50)32-14-18-36(19-15-32)48-26-24-47(25-27-48)29-33-8-6-7-11-39(33)31-12-16-34(43)17-13-31/h3-21,28,35,44H,22-27,29-30H2,1-2H3,(H,45,50)/t35-/m1/s1",HPLNQCPCUACXLM-PGUFJCEWSA-N,Antagonist,Antagonist,,,,,pKi,,9.3,,Ki,,0.5,,<,,,,17256834, Bcl-2-like 1,2845,Q07817,Human,obatoclax,11086,,46930997,COc1c/c(=C\2/C=c3c(=N2)cccc3)/[nH]/c/1=C\c1[nH]c(cc1C)C,"InChI=1S/C20H19N3O/c1-12-8-13(2)21-16(12)10-19-20(24-3)11-18(23-19)17-9-14-6-4-5-7-15(14)22-17/h4-11,21,23H,1-3H3/b18-17+,19-10-",CVCLJVVBHYOXDC-LKIBBAOUSA-N,Antagonist,Antagonist,,,,,pKi,,5.33,,Ki,,4690.0,,=,In vitro antagonism determined in a fluorescence polarisation assay.,,,29407973, Bcl-2-like 1,2845,Q07817,Human,A-1331852,11102,,71565985,OC(=O)c1nc(ccc1c1cnn(c1C)CC12CC3CC(C2)CC(C1)C3)N1CCc2c(C1)c(ccc2)C(=O)Nc1nc2c(s1)cccc2,"InChI=1S/C38H38N6O3S/c1-22-29(19-39-44(22)21-38-16-23-13-24(17-38)15-25(14-23)18-38)27-9-10-33(41-34(27)36(46)47)43-12-11-26-5-4-6-28(30(26)20-43)35(45)42-37-40-31-7-2-3-8-32(31)48-37/h2-10,19,23-25H,11-18,20-21H2,1H3,(H,46,47)(H,40,42,45)",QCQQONWEDCOTBV-UHFFFAOYSA-N,Antagonist,Antagonist,,,,,pEC50,,8.2,,EC50,,6.3,,=,MOLT-4 cell viability assay.,,,, Bcl-2-like 1,2845,Q07817,Human,AZD4320,11781,,86661883,CN(CC[C@H](CSc1ccccc1)Nc1c(cc(cc1)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCC(CC1)[C@H](c1ccccc1c1ccc(cc1)Cl)O)S(=O)(=O)C(F)(F)F)CCO,"InChI=1S/C45H48ClF3N4O7S3/c1-52(27-28-54)24-23-35(30-61-37-7-3-2-4-8-37)50-41-20-19-38(29-42(41)62(57,58)45(47,48)49)63(59,60)51-44(56)33-13-17-36(18-14-33)53-25-21-32(22-26-53)43(55)40-10-6-5-9-39(40)31-11-15-34(46)16-12-31/h2-20,29,32,35,43,50,54-55H,21-28,30H2,1H3,(H,51,56)/t35-,43-/m1/s1",UNEJSHNDABUZNY-UJNHCCGESA-N,Antagonist,Antagonist,,,,,pIC50,,9.0,,IC50,,1.0,,=,,,,, Bcl-2-like 1,2845,Q07817,Human,APG-1252-M1,13070,,90279478,CC(C)N1C(C)=C(C(=C1C2=CC=C(Cl)C=C2)C3=CC(=CC(F)=C3)N4CCN(CC4)C5=CC=C(NS(=O)(=O)C6=CC=C(N[C@H](CCN7CCC(CC7)C(O)=O)CSC8=CC=CC=C8)C(=C6)S(=O)(=O)C(F)(F)F)C=C5)S(C)(=O)=O,"InChI=1S/C54H59ClF4N6O8S4/c1-35(2)65-36(3)52(75(4,68)69)50(51(65)37-10-12-40(55)13-11-37)39-30-41(56)32-45(31-39)64-28-26-63(27-29-64)44-16-14-42(15-17-44)61-77(72,73)47-18-19-48(49(33-47)76(70,71)54(57,58)59)60-43(34-74-46-8-6-5-7-9-46)22-25-62-23-20-38(21-24-62)53(66)67/h5-19,30-33,35,38,43,60-61H,20-29,34H2,1-4H3,(H,66,67)/t43-/m1/s1",OGHPBBHWAPIYHS-VZUYHUTRSA-N,Antagonist,Antagonist,,,,,pKi,,9.87,,Ki,,0.134,,=,,,,, Bcl-2-like 1,2845,Q07817,Human,lisaftoclax,13108,,137355972,C1CC2(C1)CCC(=C(C2)C3=CC=C(C=C3)Cl)CN4CCN(CC4)C5=CC(=C(C=C5)C(=O)NS(=O)(=O)C6=CC(=C(C=C6)NC[C@H]7COCCO7)[N+](=O)[O-])OC8=CN=C9C(=C8)C=CN9,"InChI=1S/C45H48ClN7O8S/c46-33-4-2-30(3-5-33)39-25-45(12-1-13-45)14-10-32(39)28-51-16-18-52(19-17-51)34-6-8-38(42(23-34)61-35-22-31-11-15-47-43(31)49-26-35)44(54)50-62(57,58)37-7-9-40(41(24-37)53(55)56)48-27-36-29-59-20-21-60-36/h2-9,11,15,22-24,26,36,48H,1,10,12-14,16-21,25,27-29H2,(H,47,49)(H,50,54)/t36-/m0/s1",FNBXDBIYRAPDPI-BHVANESWSA-N,Inhibitor,Inhibition,,,,,pKi,,9.3,,Ki,,0.5,,<,,,,32093809,